Remove Diabetes Remove Electronics Remove Events Remove Hospital
article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Setting or Dataset Five electronic systems of community clinic. Population Studied individuals with comorbidity of hypertension and type 2 diabetes.

article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

Cardiovascular Events The SELECT trial 1 randomized 17,604 patients with preexisting CVD and overweight/obesity. Relative risk for cardiovascular events was reduced by 19% (RRR), while the absolute risk was reduced by 1.5% 5 In March 2024, Novo Nordisk announced that 24% less CKD-related events occurred in the intervention group.

Diabetes 130
article thumbnail

Allowing Patients to Die: Louise Aronson and Bill Andereck

GeriPal

He had a 14 month recovery in hospital and rehab and continually asked to have life sustaining treatment suspended so that he could be allowed to die. So she bled a lot and finally called for help and was transferred to the hospital, where she started crashing in the trauma room. She didn’t die in the hospital.